Menu
CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
525 French Rd
Utica, New York 13502-5945
Phone: 13156243208
www.conmed.com
Conmed Corp (CNMD) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Insights
The following slide deck was published by CONMED Corporation in conjunction with their 2024 Q1 earnings call.
Call End: CONMED Corporation (NYSE:NYSE:CNMD)Q1 2024 Earnings Conference CallApril 24, 2024, 16:30 PM ETCompany ParticipantsCurt Hartman - Chair, President…
Q1 2024 Conmed Corp Earnings Call Transcript
Conmed (NYSE: CNMD ) just reported results for the first quarter of 2024. Conmed reported earnings per share of 79 cents. This was above the analyst estimate for EPS of 74 cents. The company reported revenue of $312.27 million. This was 1.79% better than the analyst estimate for revenue of $306.78 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Strategy underperformed the benchmark in the quarter. The small-cap growth universe revealed a stark dichotomy despite the positive performance of the benchmark Russell 2000 Growth Index, which […]
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and Jetzt den vollständigen Artikel lesen
Despite significant challenges, the U.S. economy has showcased remarkable resilience. Fears of an imminent recession have been allayed by two consecutive quarters of robust GDP growth exceeding 3%. Consumer stocks remain strong, with record-high household net worth and solid personal income growth. Looking ahead, the Fed’s cautious approach reinforces confidence in the future of the U.S. economy. Our economy is looking strong, and the following companies’ 52-week lows offer an opportune time to invest for long-term growth. If you don’t buy now, prices are likely to rise, and you may miss out on getting a good deal on these retirement stocks to buy. Starbucks (SBUX) Source: monticello / Shutterstock.com Starbucks (NASDAQ: SBUX ) is a leading roaster, marketer and retailer of coffee that operates in 86 countries. At a current valuation of $90.71, Starbucks saw unshakeable growth of $17.75 in the past 5 years. Starbucks reported a revenue of $35.98 billion ending the fiscal year of 2023, marking an 11.55% YOY growth from the previous year.
